nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaliplatin—GSTT1—Etoposide—muscle cancer	0.213	0.24	CbGbCtD
Oxaliplatin—GSTP1—Etoposide—muscle cancer	0.133	0.15	CbGbCtD
Oxaliplatin—NQO1—Doxorubicin—muscle cancer	0.0996	0.112	CbGbCtD
Oxaliplatin—SLC22A3—Vincristine—muscle cancer	0.0602	0.068	CbGbCtD
Oxaliplatin—CYP1A1—Dacarbazine—muscle cancer	0.0455	0.0514	CbGbCtD
Oxaliplatin—ABCG2—Dactinomycin—muscle cancer	0.0427	0.0483	CbGbCtD
Oxaliplatin—CYP2E1—Dacarbazine—muscle cancer	0.0351	0.0397	CbGbCtD
Oxaliplatin—CYP1B1—Doxorubicin—muscle cancer	0.0346	0.0391	CbGbCtD
Oxaliplatin—ABCC2—Vincristine—muscle cancer	0.0291	0.0329	CbGbCtD
Oxaliplatin—ABCC2—Etoposide—muscle cancer	0.0267	0.0301	CbGbCtD
Oxaliplatin—ABCG2—Vincristine—muscle cancer	0.0263	0.0297	CbGbCtD
Oxaliplatin—ABCG2—Etoposide—muscle cancer	0.0241	0.0272	CbGbCtD
Oxaliplatin—CYP1A2—Dacarbazine—muscle cancer	0.0203	0.023	CbGbCtD
Oxaliplatin—ABCC2—Doxorubicin—muscle cancer	0.0182	0.0205	CbGbCtD
Oxaliplatin—ABCC2—Methotrexate—muscle cancer	0.0176	0.0199	CbGbCtD
Oxaliplatin—CYP2E1—Etoposide—muscle cancer	0.0172	0.0194	CbGbCtD
Oxaliplatin—ABCG2—Doxorubicin—muscle cancer	0.0164	0.0186	CbGbCtD
Oxaliplatin—ABCG2—Methotrexate—muscle cancer	0.0159	0.018	CbGbCtD
Oxaliplatin—CYP1A2—Etoposide—muscle cancer	0.00994	0.0112	CbGbCtD
Oxaliplatin—GSTP1—Diurnally Regulated Genes with Circadian Orthologs—MYF6—muscle cancer	0.00278	0.0717	CbGpPWpGaD
Oxaliplatin—MT1A—renal system—muscle cancer	0.00233	0.0306	CbGeAlD
Oxaliplatin—GSTM1—C-MYB transcription factor network—MYF6—muscle cancer	0.00209	0.0539	CbGpPWpGaD
Oxaliplatin—MT2A—renal system—muscle cancer	0.00194	0.0255	CbGeAlD
Oxaliplatin—GSTT1—renal system—muscle cancer	0.0019	0.025	CbGeAlD
Oxaliplatin—ATP7B—cardiac atrium—muscle cancer	0.00187	0.0246	CbGeAlD
Oxaliplatin—MPO—C-MYB transcription factor network—MYF6—muscle cancer	0.00178	0.0458	CbGpPWpGaD
Oxaliplatin—ATP7A—renal system—muscle cancer	0.00168	0.0221	CbGeAlD
Oxaliplatin—MT1A—Copper homeostasis—FOXO1—muscle cancer	0.00154	0.0397	CbGpPWpGaD
Oxaliplatin—SOD1—smooth muscle tissue—muscle cancer	0.00153	0.0201	CbGeAlD
Oxaliplatin—ATP7B—vagina—muscle cancer	0.00151	0.0199	CbGeAlD
Oxaliplatin—MT1A—testis—muscle cancer	0.00151	0.0198	CbGeAlD
Oxaliplatin—SLC31A1—renal system—muscle cancer	0.00143	0.0188	CbGeAlD
Oxaliplatin—GSTM1—renal system—muscle cancer	0.0014	0.0184	CbGeAlD
Oxaliplatin—ATP7B—head—muscle cancer	0.0014	0.0184	CbGeAlD
Oxaliplatin—ATP7B—testis—muscle cancer	0.00135	0.0177	CbGeAlD
Oxaliplatin—SOD1—cardiac atrium—muscle cancer	0.00132	0.0173	CbGeAlD
Oxaliplatin—ATP7A—tendon—muscle cancer	0.00131	0.0172	CbGeAlD
Oxaliplatin—MT2A—head—muscle cancer	0.0013	0.0171	CbGeAlD
Oxaliplatin—SLC31A1—cardiac atrium—muscle cancer	0.00128	0.0169	CbGeAlD
Oxaliplatin—GSTT1—head—muscle cancer	0.00127	0.0167	CbGeAlD
Oxaliplatin—ATP7A—bone marrow—muscle cancer	0.00127	0.0167	CbGeAlD
Oxaliplatin—MT2A—testis—muscle cancer	0.00125	0.0165	CbGeAlD
Oxaliplatin—ATP7A—vagina—muscle cancer	0.00122	0.016	CbGeAlD
Oxaliplatin—ATP7B—Copper homeostasis—FOXO1—muscle cancer	0.00117	0.0301	CbGpPWpGaD
Oxaliplatin—GSTP1—embryo—muscle cancer	0.00116	0.0152	CbGeAlD
Oxaliplatin—SOD1—tendon—muscle cancer	0.00115	0.0151	CbGeAlD
Oxaliplatin—SLC31A1—tendon—muscle cancer	0.00112	0.0147	CbGeAlD
Oxaliplatin—SOD1—bone marrow—muscle cancer	0.00111	0.0146	CbGeAlD
Oxaliplatin—SLC22A2—renal system—muscle cancer	0.00111	0.0146	CbGeAlD
Oxaliplatin—ATP7A—testis—muscle cancer	0.00109	0.0143	CbGeAlD
Oxaliplatin—SLC31A1—bone marrow—muscle cancer	0.00108	0.0142	CbGeAlD
Oxaliplatin—SOD1—vagina—muscle cancer	0.00107	0.014	CbGeAlD
Oxaliplatin—SLC31A1—vagina—muscle cancer	0.00104	0.0136	CbGeAlD
Oxaliplatin—NQO1—Validated transcriptional targets of TAp63 isoforms—TP63—muscle cancer	0.00104	0.0267	CbGpPWpGaD
Oxaliplatin—NQO1—smooth muscle tissue—muscle cancer	0.00102	0.0134	CbGeAlD
Oxaliplatin—ATP7A—Copper homeostasis—FOXO1—muscle cancer	0.000994	0.0256	CbGpPWpGaD
Oxaliplatin—SLC22A3—embryo—muscle cancer	0.00099	0.013	CbGeAlD
Oxaliplatin—NQO1—renal system—muscle cancer	0.000981	0.0129	CbGeAlD
Oxaliplatin—SLC31A1—head—muscle cancer	0.000959	0.0126	CbGeAlD
Oxaliplatin—SLC31A1—Copper homeostasis—FOXO1—muscle cancer	0.000953	0.0245	CbGpPWpGaD
Oxaliplatin—SOD1—testis—muscle cancer	0.000951	0.0125	CbGeAlD
Oxaliplatin—GSTM1—head—muscle cancer	0.000936	0.0123	CbGeAlD
Oxaliplatin—MT2A—Copper homeostasis—FOXO1—muscle cancer	0.000934	0.0241	CbGpPWpGaD
Oxaliplatin—SLC31A1—testis—muscle cancer	0.000926	0.0122	CbGeAlD
Oxaliplatin—MT1A—Copper homeostasis—MDM2—muscle cancer	0.000925	0.0238	CbGpPWpGaD
Oxaliplatin—GSTP1—smooth muscle tissue—muscle cancer	0.00091	0.012	CbGeAlD
Oxaliplatin—GSTM1—testis—muscle cancer	0.000904	0.0119	CbGeAlD
Oxaliplatin—MPO—renal system—muscle cancer	0.000902	0.0118	CbGeAlD
Oxaliplatin—GSTP1—renal system—muscle cancer	0.000876	0.0115	CbGeAlD
Oxaliplatin—GSTM1—C-MYB transcription factor network—MYOD1—muscle cancer	0.000833	0.0215	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—CD34—muscle cancer	0.000833	0.0215	CbGpPWpGaD
Oxaliplatin—GSTP1—cardiac atrium—muscle cancer	0.000785	0.0103	CbGeAlD
Oxaliplatin—SLC22A1—renal system—muscle cancer	0.000784	0.0103	CbGeAlD
Oxaliplatin—SLC22A3—smooth muscle tissue—muscle cancer	0.000778	0.0102	CbGeAlD
Oxaliplatin—NQO1—tendon—muscle cancer	0.000765	0.0101	CbGeAlD
Oxaliplatin—SLC22A3—renal system—muscle cancer	0.000749	0.00984	CbGeAlD
Oxaliplatin—CYP1B1—smooth muscle tissue—muscle cancer	0.000715	0.0094	CbGeAlD
Oxaliplatin—NQO1—vagina—muscle cancer	0.00071	0.00933	CbGeAlD
Oxaliplatin—MPO—C-MYB transcription factor network—CD34—muscle cancer	0.000708	0.0183	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—MYOD1—muscle cancer	0.000708	0.0183	CbGpPWpGaD
Oxaliplatin—ABCC2—renal system—muscle cancer	0.000703	0.00924	CbGeAlD
Oxaliplatin—ATP7B—Copper homeostasis—MDM2—muscle cancer	0.000701	0.0181	CbGpPWpGaD
Oxaliplatin—CYP1B1—renal system—muscle cancer	0.000689	0.00905	CbGeAlD
Oxaliplatin—GSTP1—tendon—muscle cancer	0.000684	0.00899	CbGeAlD
Oxaliplatin—MPO—bone marrow—muscle cancer	0.000682	0.00896	CbGeAlD
Oxaliplatin—SOD1—AGE/RAGE pathway—FOXO4—muscle cancer	0.000669	0.0172	CbGpPWpGaD
Oxaliplatin—CA4—renal system—muscle cancer	0.000668	0.00877	CbGeAlD
Oxaliplatin—GSTP1—bone marrow—muscle cancer	0.000663	0.00871	CbGeAlD
Oxaliplatin—NQO1—head—muscle cancer	0.000656	0.00862	CbGeAlD
Oxaliplatin—GSTP1—vagina—muscle cancer	0.000635	0.00834	CbGeAlD
Oxaliplatin—NQO1—testis—muscle cancer	0.000634	0.00833	CbGeAlD
Oxaliplatin—MPO—head—muscle cancer	0.000603	0.00793	CbGeAlD
Oxaliplatin—SOD1—Copper homeostasis—FOXO1—muscle cancer	0.000598	0.0154	CbGpPWpGaD
Oxaliplatin—CA4—cardiac atrium—muscle cancer	0.000598	0.00786	CbGeAlD
Oxaliplatin—ATP7A—Copper homeostasis—MDM2—muscle cancer	0.000596	0.0154	CbGpPWpGaD
Oxaliplatin—GSTP1—head—muscle cancer	0.000586	0.0077	CbGeAlD
Oxaliplatin—MPO—testis—muscle cancer	0.000583	0.00766	CbGeAlD
Oxaliplatin—SLC31A1—Copper homeostasis—MDM2—muscle cancer	0.000572	0.0147	CbGpPWpGaD
Oxaliplatin—SLC22A1—vagina—muscle cancer	0.000568	0.00746	CbGeAlD
Oxaliplatin—GSTP1—testis—muscle cancer	0.000566	0.00744	CbGeAlD
Oxaliplatin—MT2A—Copper homeostasis—MDM2—muscle cancer	0.000561	0.0144	CbGpPWpGaD
Oxaliplatin—ABCC2—tendon—muscle cancer	0.000549	0.00721	CbGeAlD
Oxaliplatin—SLC22A3—vagina—muscle cancer	0.000543	0.00713	CbGeAlD
Oxaliplatin—CYP1B1—tendon—muscle cancer	0.000538	0.00706	CbGeAlD
Oxaliplatin—MT1A—Copper homeostasis—TP53—muscle cancer	0.000531	0.0137	CbGpPWpGaD
Oxaliplatin—SLC22A1—head—muscle cancer	0.000525	0.00689	CbGeAlD
Oxaliplatin—CA4—tendon—muscle cancer	0.000521	0.00685	CbGeAlD
Oxaliplatin—CA4—bone marrow—muscle cancer	0.000505	0.00663	CbGeAlD
Oxaliplatin—SLC22A3—head—muscle cancer	0.000501	0.00659	CbGeAlD
Oxaliplatin—SOD1—AGE/RAGE pathway—FOXO1—muscle cancer	0.000494	0.0127	CbGpPWpGaD
Oxaliplatin—CYP1A2—renal system—muscle cancer	0.000494	0.00648	CbGeAlD
Oxaliplatin—CYP1A1—renal system—muscle cancer	0.000487	0.0064	CbGeAlD
Oxaliplatin—SLC22A3—testis—muscle cancer	0.000484	0.00636	CbGeAlD
Oxaliplatin—CYP1B1—head—muscle cancer	0.000461	0.00605	CbGeAlD
Oxaliplatin—SOD1—Platelet degranulation—IGF2—muscle cancer	0.000461	0.0119	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—CDKN2A—muscle cancer	0.000456	0.0117	CbGpPWpGaD
Oxaliplatin—ABCC2—testis—muscle cancer	0.000455	0.00597	CbGeAlD
Oxaliplatin—CA4—head—muscle cancer	0.000447	0.00587	CbGeAlD
Oxaliplatin—CYP1B1—testis—muscle cancer	0.000445	0.00585	CbGeAlD
Oxaliplatin—CYP2E1—renal system—muscle cancer	0.000444	0.00583	CbGeAlD
Oxaliplatin—SOD1—Response to elevated platelet cytosolic Ca2+—IGF2—muscle cancer	0.000439	0.0113	CbGpPWpGaD
Oxaliplatin—CYP1A1—cardiac atrium—muscle cancer	0.000436	0.00573	CbGeAlD
Oxaliplatin—CA4—testis—muscle cancer	0.000432	0.00567	CbGeAlD
Oxaliplatin—ATP7A—Cellular responses to stress—HMGA1—muscle cancer	0.000409	0.0105	CbGpPWpGaD
Oxaliplatin—ATP7B—Copper homeostasis—TP53—muscle cancer	0.000402	0.0104	CbGpPWpGaD
Oxaliplatin—CYP1B1—Melatonin metabolism and effects—FOXO1—muscle cancer	0.00039	0.01	CbGpPWpGaD
Oxaliplatin—ABCG2—bone marrow—muscle cancer	0.000388	0.00509	CbGeAlD
Oxaliplatin—ABCC2—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000377	0.00971	CbGpPWpGaD
Oxaliplatin—ABCG2—vagina—muscle cancer	0.000371	0.00488	CbGeAlD
Oxaliplatin—SOD1—Copper homeostasis—MDM2—muscle cancer	0.000359	0.00925	CbGpPWpGaD
Oxaliplatin—CYP1A1—vagina—muscle cancer	0.000353	0.00463	CbGeAlD
Oxaliplatin—CYP2E1—tendon—muscle cancer	0.000347	0.00455	CbGeAlD
Oxaliplatin—ATP7A—Copper homeostasis—TP53—muscle cancer	0.000342	0.00881	CbGpPWpGaD
Oxaliplatin—ABCG2—testis—muscle cancer	0.000331	0.00435	CbGeAlD
Oxaliplatin—SLC31A1—Copper homeostasis—TP53—muscle cancer	0.000328	0.00845	CbGpPWpGaD
Oxaliplatin—CYP1A1—head—muscle cancer	0.000326	0.00428	CbGeAlD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	0.000325	0.00836	CbGpPWpGaD
Oxaliplatin—MT2A—Copper homeostasis—TP53—muscle cancer	0.000322	0.00829	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—KIT—muscle cancer	0.000319	0.00821	CbGpPWpGaD
Oxaliplatin—NQO1—Validated transcriptional targets of TAp63 isoforms—CDKN2A—muscle cancer	0.000305	0.00787	CbGpPWpGaD
Oxaliplatin—CYP2E1—head—muscle cancer	0.000297	0.0039	CbGeAlD
Oxaliplatin—NQO1—Validated transcriptional targets of TAp63 isoforms—MDM2—muscle cancer	0.000296	0.00763	CbGpPWpGaD
Oxaliplatin—CYP2E1—testis—muscle cancer	0.000287	0.00377	CbGeAlD
Oxaliplatin—MPO—C-MYB transcription factor network—KIT—muscle cancer	0.000271	0.00698	CbGpPWpGaD
Oxaliplatin—SOD1—Amyotrophic lateral sclerosis (ALS)—TP53—muscle cancer	0.000265	0.00682	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—CDKN2A—muscle cancer	0.000259	0.00667	CbGpPWpGaD
Oxaliplatin—NQO1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	0.000256	0.00659	CbGpPWpGaD
Oxaliplatin—MT2A—AP-1 transcription factor network—TP53—muscle cancer	0.000254	0.00653	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—HMGA1—muscle cancer	0.000246	0.00634	CbGpPWpGaD
Oxaliplatin—GSTM1—C-MYB transcription factor network—PTGS2—muscle cancer	0.000242	0.00623	CbGpPWpGaD
Oxaliplatin—CYP1A1—Melatonin metabolism and effects—FOXO1—muscle cancer	0.00024	0.00619	CbGpPWpGaD
Oxaliplatin—SOD1—Selenium Micronutrient Network—PTGS2—muscle cancer	0.000227	0.00585	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—CDKN2A—muscle cancer	0.00022	0.00567	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—ANGPT2—muscle cancer	0.000217	0.00558	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—HMGA1—muscle cancer	0.000215	0.00553	CbGpPWpGaD
Oxaliplatin—SOD1—Copper homeostasis—TP53—muscle cancer	0.000206	0.00531	CbGpPWpGaD
Oxaliplatin—MPO—C-MYB transcription factor network—PTGS2—muscle cancer	0.000206	0.0053	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.000204	0.00526	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—FH—muscle cancer	0.000202	0.0052	CbGpPWpGaD
Oxaliplatin—MPO—Selenium Micronutrient Network—PTGS2—muscle cancer	0.000198	0.00511	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet degranulation—VEGFA—muscle cancer	0.000193	0.00498	CbGpPWpGaD
Oxaliplatin—SOD1—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	0.000184	0.00474	CbGpPWpGaD
Oxaliplatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	0.000178	0.00458	CbGpPWpGaD
Oxaliplatin—SOD1—Folate Metabolism—TP53—muscle cancer	0.00017	0.00439	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—CDKN2A—muscle cancer	0.000168	0.00432	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—MDM2—muscle cancer	0.000163	0.00419	CbGpPWpGaD
Oxaliplatin—CYP1B1—Tryptophan metabolism—MDM2—muscle cancer	0.000162	0.00417	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—CD34—muscle cancer	0.000158	0.00407	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	0.000156	0.00402	CbGpPWpGaD
Oxaliplatin—CYP1A2—Melatonin metabolism and effects—FOXO1—muscle cancer	0.000153	0.00394	CbGpPWpGaD
Oxaliplatin—CYP1A1—PPARA activates gene expression—MED12—muscle cancer	0.000151	0.00388	CbGpPWpGaD
Oxaliplatin—MPO—Folate Metabolism—TP53—muscle cancer	0.000149	0.00383	CbGpPWpGaD
Oxaliplatin—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—muscle cancer	0.000147	0.0038	CbGpPWpGaD
Oxaliplatin—CYP1B1—Arachidonic acid metabolism—PTGS2—muscle cancer	0.000146	0.00376	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—muscle cancer	0.000142	0.00367	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—FH—muscle cancer	0.00013	0.00335	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—VEGFA—muscle cancer	0.000123	0.00318	CbGpPWpGaD
Oxaliplatin—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	0.000123	0.00316	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—FH—muscle cancer	0.000115	0.00297	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—MED12—muscle cancer	0.000114	0.00294	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—FH—muscle cancer	0.000111	0.00285	CbGpPWpGaD
Oxaliplatin—ABCG2—Fluoropyrimidine Activity—TP53—muscle cancer	0.00011	0.00284	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—FH—muscle cancer	0.000108	0.00278	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—FOXO4—muscle cancer	0.000107	0.00277	CbGpPWpGaD
Oxaliplatin—CYP2E1—Tryptophan metabolism—MDM2—muscle cancer	0.000106	0.00272	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—IGF2—muscle cancer	0.000105	0.00271	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—ENO2—muscle cancer	0.000104	0.00268	CbGpPWpGaD
Oxaliplatin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	0.000102	0.00262	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—CDKN2A—muscle cancer	0.000101	0.0026	CbGpPWpGaD
Oxaliplatin—CYP1A1—Tryptophan metabolism—MDM2—muscle cancer	9.96e-05	0.00257	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—MDM2—muscle cancer	9.79e-05	0.00252	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	9.6e-05	0.00247	CbGpPWpGaD
Oxaliplatin—ATP7A—Cellular responses to stress—TP53—muscle cancer	9.33e-05	0.0024	CbGpPWpGaD
Oxaliplatin—CYP1A1—Arachidonic acid metabolism—PTGS2—muscle cancer	8.98e-05	0.00231	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—CDKN2A—muscle cancer	8.8e-05	0.00227	CbGpPWpGaD
Oxaliplatin—SOD1—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	8.57e-05	0.00221	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—MDM2—muscle cancer	8.54e-05	0.0022	CbGpPWpGaD
Oxaliplatin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	8.37e-05	0.00216	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—FOXO1—muscle cancer	7.94e-05	0.00204	CbGpPWpGaD
Oxaliplatin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	7.57e-05	0.00195	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—VEGFA—muscle cancer	7.43e-05	0.00191	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—FH—muscle cancer	7.43e-05	0.00191	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—MED12—muscle cancer	7.35e-05	0.00189	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—ENO2—muscle cancer	6.7e-05	0.00173	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	6.57e-05	0.00169	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—MED12—muscle cancer	6.51e-05	0.00168	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—VEGFA—muscle cancer	6.48e-05	0.00167	CbGpPWpGaD
Oxaliplatin—CYP1A2—Tryptophan metabolism—MDM2—muscle cancer	6.35e-05	0.00164	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—MED12—muscle cancer	6.25e-05	0.00161	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	6.12e-05	0.00158	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—MED12—muscle cancer	6.09e-05	0.00157	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—KIT—muscle cancer	6.05e-05	0.00156	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—ENO2—muscle cancer	5.94e-05	0.00153	CbGpPWpGaD
Oxaliplatin—CYP1A2—Arachidonic acid metabolism—PTGS2—muscle cancer	5.73e-05	0.00148	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—ENO2—muscle cancer	5.69e-05	0.00147	CbGpPWpGaD
Oxaliplatin—SOD1—Cellular responses to stress—TP53—muscle cancer	5.62e-05	0.00145	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—ENO2—muscle cancer	5.55e-05	0.00143	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—FH—muscle cancer	5.18e-05	0.00133	CbGpPWpGaD
Oxaliplatin—GSTP1—Cellular responses to stress—TP53—muscle cancer	4.9e-05	0.00126	CbGpPWpGaD
Oxaliplatin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	4.82e-05	0.00124	CbGpPWpGaD
Oxaliplatin—MT2A—Immune System—MDM2—muscle cancer	4.76e-05	0.00123	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—FH—muscle cancer	4.71e-05	0.00121	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—FH—muscle cancer	4.66e-05	0.0012	CbGpPWpGaD
Oxaliplatin—SLC22A2—Transmission across Chemical Synapses—MDM2—muscle cancer	4.49e-05	0.00116	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—VEGFA—muscle cancer	4.42e-05	0.00114	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—FH—muscle cancer	4.34e-05	0.00112	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—MED12—muscle cancer	4.2e-05	0.00108	CbGpPWpGaD
Oxaliplatin—SLC22A1—Transmission across Chemical Synapses—MDM2—muscle cancer	4.19e-05	0.00108	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—MED12—muscle cancer	4.04e-05	0.00104	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—ENO2—muscle cancer	3.83e-05	0.000986	CbGpPWpGaD
Oxaliplatin—GSTT1—Metabolism—PTGS2—muscle cancer	3.62e-05	0.000932	CbGpPWpGaD
Oxaliplatin—SLC22A2—Neuronal System—MDM2—muscle cancer	3.44e-05	0.000887	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—FH—muscle cancer	3.38e-05	0.000871	CbGpPWpGaD
Oxaliplatin—SOD1—Hemostasis—TP53—muscle cancer	3.34e-05	0.00086	CbGpPWpGaD
Oxaliplatin—SLC22A1—Neuronal System—MDM2—muscle cancer	3.21e-05	0.000827	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—FH—muscle cancer	3.19e-05	0.000821	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—MED12—muscle cancer	2.92e-05	0.000753	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—ENO2—muscle cancer	2.67e-05	0.000687	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—MED12—muscle cancer	2.66e-05	0.000685	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—MED12—muscle cancer	2.63e-05	0.000678	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.58e-05	0.000664	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—MED12—muscle cancer	2.45e-05	0.000632	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—ENO2—muscle cancer	2.43e-05	0.000625	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—ENO2—muscle cancer	2.4e-05	0.000618	CbGpPWpGaD
Oxaliplatin—GSTM1—Metabolism—PTGS2—muscle cancer	2.33e-05	0.000601	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—ENO2—muscle cancer	2.24e-05	0.000576	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	2.09e-05	0.000537	CbGpPWpGaD
Oxaliplatin—CA4—Metabolism—PTGS2—muscle cancer	2.07e-05	0.000533	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—FH—muscle cancer	2.03e-05	0.000524	CbGpPWpGaD
Oxaliplatin—GSTP1—Metabolism—PTGS2—muscle cancer	1.98e-05	0.000511	CbGpPWpGaD
Oxaliplatin—NQO1—Metabolism—PTGS2—muscle cancer	1.93e-05	0.000498	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—MED12—muscle cancer	1.91e-05	0.000492	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—MED12—muscle cancer	1.8e-05	0.000464	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—ENO2—muscle cancer	1.74e-05	0.000449	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—ENO2—muscle cancer	1.64e-05	0.000423	CbGpPWpGaD
Oxaliplatin—SLC22A3—Metabolism—PTGS2—muscle cancer	1.33e-05	0.000343	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.28e-05	0.000331	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—MED12—muscle cancer	1.15e-05	0.000296	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—ENO2—muscle cancer	1.05e-05	0.00027	CbGpPWpGaD
Oxaliplatin—CYP1B1—Metabolism—PTGS2—muscle cancer	9.29e-06	0.000239	CbGpPWpGaD
Oxaliplatin—ABCG2—Metabolism—PTGS2—muscle cancer	8.45e-06	0.000218	CbGpPWpGaD
Oxaliplatin—SLC22A2—Metabolism—PTGS2—muscle cancer	8.36e-06	0.000215	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	8.19e-06	0.000211	CbGpPWpGaD
Oxaliplatin—SLC22A1—Metabolism—PTGS2—muscle cancer	7.79e-06	0.000201	CbGpPWpGaD
Oxaliplatin—CYP2E1—Metabolism—PTGS2—muscle cancer	6.07e-06	0.000156	CbGpPWpGaD
Oxaliplatin—CYP1A1—Metabolism—PTGS2—muscle cancer	5.72e-06	0.000147	CbGpPWpGaD
Oxaliplatin—CYP1A2—Metabolism—PTGS2—muscle cancer	3.65e-06	9.39e-05	CbGpPWpGaD
